1. | mokakaippnxxtsz7 | |
2. | keiththewolf94 | |
3. | coskot | |
4. | phmolter | |
5. | mjones5944 |
1. | mokakaippnxxtsz7 | |
2. | keiththewolf94 | |
3. | coskot | |
4. | phmolter | |
5. | mjones5944 |
1. | phmolter 02/05/2018 Stifel Nicolaus cuts PT to $20 from $25 |
2. | coskot 02/05/2018 BOUNCE WHEN THE MARKET RECOVERS |
3. | keiththewolf94 09/28/2018 Receives FDA orphan drug designation for Relacorilant |
4. | keiththewolf94 02/05/2018 hoping $16 holds |
5. | mokakaippnxxtsz7 02/26/2018 Corcept Therapeutics Announces 2017 Financial Results and Positive Interim Results of Relacorilant Phase 2 Trial |
6. | mjones5944 02/05/2018 ouch! {Image} |
7. | mjones5944 02/02/2018 Corcept Therapeutics Announces Fourth Quarter and Full-Year 2017 Preliminary Selected Financial Results; Provides 2018 Revenue Guidance |
8. | keiththewolf94 02/22/2018 Reports Relacorilant Phase 2 Trial interim results |